Obesity is an emerging independent risk factor for susceptibility to and severity of
coronavirus disease 2019 (COVID‐19) caused by the severe acute respiratory syndrome …

One of the significant complications of severe COVID-19 infections is a coagulopathy that
seems to be related to the occurrence of venous and arterial thromboembolic disease. The …

The aim of this study was to (1) analyze blood viscosity, red blood cell (RBC) deformability,
and aggregation in hospitalized patients with Coronavirus disease 19 (COVID‐19);(2) test …

Background Hypercoagulability and thromboembolism are prominent features of severe
COVID‐19, and ongoing anticoagulant use might be protective. Methods We conducted a …

Lactoferrin (Lf) is a cationic glycoprotein synthetized by exocrine glands and is present in all
human secretions. It is also secreted by neutrophils in infection and inflammation sites. This …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected over forty
million patients worldwide. Although most coronavirus disease 2019 (COVID-19) patients …

Purpose Few data are currently available on persistent symptoms and late organ damage in
patients who have suffered from COVID-19. This prospective study aimed to evaluate the …

Objective: The aim of this review was to summarize the most common extrapulmonary
manifestations in pediatric patients with COVID-19, as well as to discuss clinical …

Lactoferrin (Lf), a multifunctional cationic glycoprotein synthesized by exocrine glands and
neutrophils, possesses an in vitro antiviral activity against SARS-CoV-2. Thus, we conducted …

Atrial fibrillation (AF) and venous thromboembolism (VTE) are highly prevalent conditions
with a significant healthcare burden, and represent the main indications for anticoagulation …